Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin

NCT01437670 · clinicaltrials.gov ↗

COMPLETED

Status

262

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: solifenacin 5mg, 10mg

Sponsor

Asan Medical Center

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]